| BASILEA PHARMACEUTICA AG |
| Schweiz |
| Gesundheit |
| CH0011432447 / A0B9GA |
| PK5 (Frankfurt) |
| FRA:PK5, ETR:PK5, PK5:GR |
| - |
| https://www.basilea.com/ |
|
Basilea Pharmaceutica Ltd is a commercial-stage biopharmaceutical company headquartered in Allschwil, Switzerland, founded in 2000 as a spin-off from F. Hoffmann-La Roche. With approximately 150 employees, it focuses on discovering, developing, and c..
>Volltext.. |
| 692.36 Mio. EUR |
| 614.11 Mio. EUR |
| 253.36 Mio. EUR |
| 60.25 Mio. EUR |
| 43.87 Mio. EUR |
| 3.58 EUR |
| 97.27 Mio. EUR |
| 32.32 Mio. EUR |
| 67.7 Mio. EUR |
| 3.3 |
| 12.52% |
| -47.63% |
| - |
| - |
| - |
| 18.06.13 - 5.4045€ |
| - |
| BASILEA |
| 18.08.26 |
|
||||
|
||||
|